Swarajya
Our View
Headlines
Magazine
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Podcasts
Archives
Blogs
News Brief
Hydroxychloroquine-Azithromycin (HCQ-AZ)
Coronavirus: Hydroxychloroquine Administered Early Decreased Mortality Hazard Ratio By 66%, A New Study Finds
Swarajya Staff
Jul 3, 2020 08:00 PM +05:30 IST
Covid-19 Antivirals: Looking For A Signal Amidst The Noise
V. Niranjan
Jun 14, 2020 12:25 PM +05:30 IST
WHO To Resume Hydroxychloroquine’s Coronavirus Trials After Study Based On Which It Was Stopped Turns Out To Be Dubious
Swarajya Staff
Jun 4, 2020 07:07 AM +05:30 IST
New ICMR Study: Sustained Intake Of HCQ Prophylaxis And Appropriate PPEs Lowers Infection Risk For Healthcare Workers
Swarajya Staff
Jun 1, 2020 10:42 AM +05:30 IST
Explained: Should India Continue Testing Anti-Malarial Drug HCQ For Treating COVID-19 After WHO Moratorium?
Swarajya Staff
May 28, 2020 05:46 PM +05:30 IST
US Begins Clinical Trial Of Hydroxychloroquine, Azithromycin
IANS
May 15, 2020 11:13 AM +05:30 IST
A New Study Unveiled By Prominent French Virologist Claims HCQ-AZ Combination Removed Novel Coronavirus In 92 Per Cent Cases
Swarajya Staff
Apr 11, 2020 01:12 PM +05:30 IST
Load More